Genmab As Stock Momentum Indicators Aroon Oscillator

GMAB Stock  USD 21.70  0.14  0.64%   
Genmab AS momentum indicators tool provides the execution environment for running the Aroon Oscillator indicator and other technical functions against Genmab AS. Genmab AS value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Aroon Oscillator indicator function is designed to identify and follow existing trends. Momentum indicators of Genmab AS are pattern recognition functions that provide distinct formation on Genmab AS potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify Time Period to run this model.

The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Aroon Oscillator was developed by Tushar S. It is calculated by subtracting the Aroon Down from the Aroon Up. The resultant number will oscillate between 100 and -100. Genmab AS Aroon Oscillator will be high when the Aroon Up is high and the Aroon Down is low, indicating a strong upward trend. The Aroon Oscillator will be low when the Aroon Down is high and the Aroon Up is low, indicating a strong downward trend. When the Up and Down are approximately equal, the Aroon Oscillator will be around zero, indicating a weak trend or consolidation.

Genmab AS Technical Analysis Modules

Most technical analysis of Genmab AS help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Genmab from various momentum indicators to cycle indicators. When you analyze Genmab charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Genmab AS Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Genmab AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genmab AS based on widely used predictive technical indicators. In general, we focus on analyzing Genmab Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genmab AS's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Genmab AS's intrinsic value. In addition to deriving basic predictive indicators for Genmab AS, we also check how macroeconomic factors affect Genmab AS price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding146.22142.85109.61104.13
PTB Ratio7.757.014.455.55
Hype
Prediction
LowEstimatedHigh
20.2421.7923.34
Details
Intrinsic
Valuation
LowRealHigh
19.5327.7629.31
Details
Naive
Forecast
LowNextHigh
21.2622.8024.35
Details
9 Analysts
Consensus
LowTargetHigh
40.7544.7849.71
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Genmab AS. Your research has to be compared to or analyzed against Genmab AS's peers to derive any actionable benefits. When done correctly, Genmab AS's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Genmab AS.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Genmab AS in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Genmab AS's short interest history, or implied volatility extrapolated from Genmab AS options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
Disruptive Technologies Idea
Disruptive Technologies
Invested one share
Power Assets Idea
Power Assets
Invested few shares
Size And Style ETFs Idea
Size And Style ETFs
Invested few shares
Corona Opportunity Idea
Corona Opportunity
Invested one share
Momentum Idea
Momentum
Invested few shares
Millennials Best Idea
Millennials Best
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
When determining whether Genmab AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genmab AS's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genmab As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genmab As Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genmab AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Genmab Stock refer to our How to Trade Genmab Stock guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genmab AS. If investors know Genmab will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genmab AS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.38)
Earnings Share
1.02
Revenue Per Share
30.6997
Quarterly Revenue Growth
0.176
Return On Assets
0.1095
The market value of Genmab AS is measured differently than its book value, which is the value of Genmab that is recorded on the company's balance sheet. Investors also form their own opinion of Genmab AS's value that differs from its market value or its book value, called intrinsic value, which is Genmab AS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genmab AS's market value can be influenced by many factors that don't directly affect Genmab AS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genmab AS's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genmab AS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genmab AS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.